Wednesday, July 1, 2026 Live from SEC EDGAR

The Wire Search Saved

···

FilingIndex

AI-powered intelligence over every SEC filing. Search in plain English. Free.

Browse

Sectors
Themes
Search

Data

SEC EDGAR
About

Legal

Privacy
Disclaimer

© 2026 FilingIndex · Data sourced from SEC EDGAR (public domain).Not investment advice.

VTVT — vTv Therapeutics Inc. SEC Filings | FilingIndex

VTVTNasdaq

vTv Therapeutics Inc.

Pharmaceutical Preparations · DE · CIK 1641489

Developing orally administered therapies for metabolic and inflammatory diseases, primarily cadisegliatin for type 1 diabetes

+ Watch View on EDGAR ↗

$129M

Market cap

$37.65

Last close

+3.8%

1D

+6.6%

5D

93K

Volume

Price · last 40 sessions+15.8%

May 4L $30.44 · H $38.43Jun 30

259

Total filings

Jun 29, 2026

Last filing

12/31

Fiscal year end

All 8-K · 171 10-Q · 33 10-K · 11 DEF 14A · 11 DEFA14A · 8 424B5 · 6 S-1/A · 6 SC 13D · 4

DEF 14ADEF 14AApr 28, 2026 DEF 14ADEF 14AApr 25, 2025 DEF 14ADEF 14AApr 25, 2024 DEF 14ADEF 14AApr 26, 2023 DEF 14ADEF 14AMay 2, 2022 DEF 14A

Similar companies

Comparable business profile · signals at a glance

GPCRStructure Therapeutics Inc.$3.1B+3.8%CTNMContineum Therapeutics, Inc.$444.2M+9.3%CRNXCrinetics Pharmaceuticals, Inc.$3.6B+1.3%MDGLMADRIGAL PHARMACEUTICALS, INC.$11.1B+1.8%SIONSionna Therapeutics, Inc.

DEF 14A

Mar 18, 2021

DEF 14ADEF 14AApr 30, 2020

DEF 14ADEF 14AMar 15, 2019

DEF 14ADEF 14AMar 16, 2018

DEF 14ADEF 14AMar 20, 2017

DEF 14ADEF 14AMar 24, 2016

$1.6B

+2.4%

LXRXLEXICON PHARMACEUTICALS, INC.$852.9M-9.1%